BCL-2 ONCOGENE PROTECTS A BONE-MARROW-DERIVED PRE-B-CELL LINE FROM 5'-FLUOR,2' DEOXYURIDINE-INDUCED APOPTOSIS
BCL-2 ONCOGENE PROTECTS A BONE-MARROW-DERIVED PRE-B-CELL LINE FROM 5'-FLUOR,2' DEOXYURIDINE-INDUCED APOPTOSIS
复制标题
DOI:
10.1006/bbrc.1993.1794
复制
发表时间:
1993-07-15
影响因子:
3.1
通讯作者:
LOPEZRIVAS, A
中科院分区:
文献类型:
--
作者:
OLIVER, FJ;MARVEL, J;LOPEZRIVAS, A
Thebcl-2protooncogene has been shown to protect haemopoietic precursors from programmed cell death after the removal of interleukin-3 (IL3). In the present report we show evidence that overexpression ofbcl-2in the pre-B-cell line BAF3 protects cells from apoptosis induced by treatment with the thymydilate synthase inhibitor 5′-fluor,2′-deoxyuridine (FDUR) in the presence of IL-3. Dose-response experiments analyzing the dependence of cell death on drug concentration indicated a marked resistence of BAF3bcl-2to FDUR treatment. Cleavage of DNA into oligonucleosome-length fragments, a characteristic of apoptosis, was observed in BAF3 cells and inhibited in the cells overexpressingbcl-2. We have determined variations in the dATP and dTTP pools after FDUR treatment. Interestingly, no differences were found between both cells in the kinetics of changes in dNTP pools. Therefore, the protective effect of theBcl-2protein on apoptosis induced by dNTP unbalance must be ascribed to a step downstream of perturbations in the synthesis of DNA precursors and before activation of endonucleolytic cleavage of chromatin.